MEDLY
LIVE

Serial Number

97436296

Owner

University Health Network

Attorney

Felicia J. Boyd

Filing Date

May 31, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MEDLY Trademark

Serial Number: 97436296

MEDLY is a trademark filed by University Health Network on May 31, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

University Health Network (11 trademarks)

101 College
Toronto, Ontario M5G1L7 , CA

Entity Type: 03

Trademark Details

Filing Date

May 31, 2022

Registration Date

Not Registered

Goods & Services

Downloadable mobile applications for use in self-management of chronic medical conditions, in particular heart failure, chronic obstructive pulmonary disease, asthma, diabetes, hypertension, cancer, pain management, and mental health; downloadable software applications for mobile devices, in particular mobile phones and computers, for monitoring and managing patient medical information; downloadable computer software for controlling and managing patient medical information; downloadable mobile applications for use in chronic medical condition research and analysis for scientific purposes; downloadable mobile applications for use in the diagnosis and treatment of chronic medical conditions, namely, cardiovascular, metabolic, respiratory, and mental health conditions; downloadable mobile applications for use in cardiovascular, metabolic, respiratory, and mental health examination and assessment for medical diagnostic purposes; Downloadable mobile applications for recording and tracking physiological and patient reported indicators; downloadable computer software featuring algorithms used to analyze mental health; downloadable mobile applications for recording and tracking physiological and patient reported indicators, generating patient self-care messages based on treatment plans, and alerting clinicians on the patient's care team when algorithms indicate action is needed; downloadable mobile applications for use in management and treatment of chronic medical conditions, namely, cancer and pain management analysis for medical and diagnostic and treatment purposes; downloadable mobile applications for use in cancer and pain management examination and assessment for medical diagnostic purposes

Electronic blood pressure monitors; heart monitors; heart rate monitors; blood glucose monitors being medical apparatus for monitoring blood glucose levels; blood pressure monitors; diabetes monitoring equipment for sampling and analyzing blood and body tissue being medical test kits for diabetes monitoring for home use

Basic clinical research in the field of medicine, namely, conducting clinical trials for others; basic clinical research in the field of medicine, namely, clinical research in the field of chronic conditions, namely, cardiovascular conditions, metabolic conditions, respiratory conditions, mental health conditions, and cancer and clinical research in the fields of radiology, chemotherapy, coronary artery bypass surgery; software as a service (SaaS) services featuring software for managing chronic conditions, namely, cardiovascular, metabolic, respiratory and mental health diagnosis and treatment; software as a service (SaaS) services for managing chronic disease; platform as a service (PaaS) featuring computer software platforms for use by healthcare professionals for use in cardiovascular, metabolic, respiratory, and mental health condition diagnosis and treatment; platform as a service (PaaS) featuring computer software platforms for use in chronic disease management; computer software technical support services, namely, troubleshooting in the nature of diagnosing computer software problems; design, development and implementation of software; computer software development in the field of mobile applications; computer software installation and maintenance; computer software system design; maintenance and updating of computer software; providing temporary use of non-downloadable computer software for connecting doctors with medical patients and providing medical information to doctors; technical support in the nature of troubleshooting to diagnose computer hardware and software problems; Web based chronic condition research and analysis services for scientific purposes being medical research services; providing temporary use of non-downloadable computer software for recording and tracking physiological and patient reported indicators; software as a service (SaaS) services featuring software for use in management of chronic conditions, namely, for cancer diagnosis and treatment and pain management; platform as a service (PaaS) featuring computer software platforms for use by healthcare professionals for use in the diagnosis and treatment of cancer and for use in pain management

Web-based chronic disease analysis services for medical and diagnostic and treatment purposes, namely, cardiovascular, metabolic, respiratory, and mental health analysis services for medical and diagnostic and treatment purposes; web-based cardiovascular, metabolic, respiratory, and mental health examination and assessment for medical diagnostic purposes; mental health services; hospital services; telemedicine services; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; dietary and nutritional guidance; medical services in the field of diabetes; home health care services; managed health care services; providing emergency health information by telephone; Web-based chronic disease analysis services for medical and diagnostic and treatment purposes, namely, cancer and pain management analysis services for medical and diagnostic and treatment purposes; web-based cancer and pain management examination and assessment for medical diagnostic purposes

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
May 19, 2026 GNFN
FINAL REFUSAL E-MAILED
May 19, 2026 GNFR
FINAL REFUSAL WRITTEN
May 19, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 10, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 14, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 14, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 14, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 17, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 16, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 16, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 16, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2025 CRFA
ASSIGNED TO LIE
May 15, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 30, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 13, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 13, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 13, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 31, 2025 RCCK
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 23, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 12, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 11, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 11, 2023 GNSL
SUSPENSION LETTER WRITTEN
Oct 11, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 5, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 5, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 17, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2022 NWOS
NEW APPLICATION ENTERED
Jun 3, 2022 NWAP